Guselkumab Treatment Outcomes and Persistence in a Nationwide Real-world Cohort of Patients with Plaque Psoriasis

• Main Authors: Tarja Mälkönen (Author), Pauliina Nuutinen (Author), Taru Hallinen (Author), Erkki Soini (Author), Riikka Nissinen (Author), Christina Wennerstöm (Author), Tapio Rantanen (Author), Johanna H. Hagman (Author), Rauno Harvima (Author), Johanna Höök-Nikanne (Author), Tiina Ilves (Author), Päivi Lintu (Author), Ken Malanin (Author), Iina Soramäki (Author), Kaisa Tasanen (Author), Arja Teho (Author), Katja Vähävihu (Author), Sari Itälinna (Author), Pekka Leinonen (Author), Piia Sarajärvi (Author), Laura Huilaja (Author), Rafael Pasternack (Author)
• Formato: Libro
• Publicado: Medical Journals Sweden, 2022-01-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Guselkumab treatment outcomes and persistence were assessed in a real-world cohort of Finnish patients with difficult-to-treat plaque psoriasis over a median follow-up of 1 year. Data on 181 patients who initiated guselkumab at the 15 study centres were collected retrospectively from the patient cha...